user

Prospective study of mycophenolate mofetil in lupus membranous nephritis.

被引：0
|
作者：
Borba, EF [1 ]
Guedes, LKN [1 ]
Figueiredo, CP [1 ]
Christmann, RB [1 ]
Gonçalves, CR [1 ]
Bonfá, E [1 ]
机构：
[1] Univ Sao Paulo, Div Rheumatol, BR-05508 Sao Paulo, Brazil
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [21] Lupus nephritis: treatment with mycophenolate mofetil
    Kapitsinou, PP
    Boletis, JN
    Skopouli, FN
    Boki, KA
    Moutsopoulos, HM
    [J]. RHEUMATOLOGY, 2004, 43 (03): : 377 - 380
  • [22] Mycophenolate mofetil for lupus nephritis: an update
    Mok, Chi Chiu
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (12) : 1353 - 1364
  • [23] Treatment of Lupus Nephritis by Mycophenolate Mofetil
    Rabrenovic, Violeta
    Poskurica, Mileta
    Kovacevic, Zoran
    Nesic, Vidosava
    Savin, Marina
    Mitic, Branka
    Dimkovic, Nada
    Cuckovic, Cedomir
    Vujic, Danica
    Pljesa, Steva
    Perunicic-Pekovic, Gordana
    Curic, Slobodan
    Mitic, Igor
    Ratkovic, Marina
    Marinkovic, Jelena
    Jovanovic, Dragan
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (04): : 297 - 303
  • [24] The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
    Dalton, Kristen
    Smith, Maxwell
    Thurman, Joshua M.
    [J]. CLINICAL KIDNEY JOURNAL, 2010, 3 (04): : 346 - 348
  • [25] The 10-Year Followup of Nephritis Trial Comparing Azathioprine and Mycophenolate Mofetil for Longterm Immunosuppression of Lupus Nephritis.
    Tamirou, Farah
    D'Cruz, David
    Sangle, Shirish
    Remy, Philippe
    Vasconcelos, Carlos
    Fiehn, Christoph
    Ayala Gutierrez, Maria del Mar
    Gilboe, Inge-Margrethe
    Tektonidou, Maria
    Blockmans, Daniel
    Ravelingien, Isabelle
    le Guern, Veronique
    Depresseux, Genevieve
    Guillevin, Loic
    Cervera, Ricard
    Houssiau, Frederic A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S426 - S427
  • [26] Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
    Boletis, John N.
    Marinaki, Smaragde
    Skalioti, Chryssanthe
    Lionaki, Sofia S.
    Iniotaki, Aliki
    Sfikakis, Petros P.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2157 - 2160
  • [27] Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome
    Yap, Desmond Y. H.
    Yu, Xueqing
    Chen, Xiang-Mei
    Lu, Fuming
    Chen, Nan
    Li, Xue-Wang
    Tang, Colin So
    Chan, Tak Mao
    [J]. NEPHROLOGY, 2012, 17 (04) : 352 - 357
  • [28] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
    Ginzler, EM
    Dooley, MA
    Aranow, C
    Kim, MY
    Buyon, J
    Merrill, JT
    Petri, M
    Gilkeson, GS
    Wallace, DJ
    Weisman, MH
    Appel, GB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2219 - 2228
  • [29] Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide
    Baños, I
    Yebra, M
    Fernández, J
    Cajal, YSR
    [J]. MEDICINA CLINICA, 2003, 121 (04): : 158 - 158
  • [30] Attenuation of murine lupus nephritis by mycophenolate mofetil
    van Bruggen, MCJ
    Walgreen, B
    Rijke, TPM
    Berden, JHM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (08): : 1407 - 1415
12345